JUSTIN BINGHAM

Justin is responsible for the commercialization of Nabsys’ OhmX platform and the democratization of structural variant analysis. He was previously part of the CENTOGENE GmbH Executive Leadership Team as the Senior Vice President of Business Development where he managed the company’s commercial business. Prior to CENTOGENE, Justin was the Head of Business Development at Synthetic Genomics, Inc. a synthetic biology company responsible for the launch and commercialization of the first bench top DNA assembly system. Justin has held scientific roles at both the Genomics Institute of the Novartis Research Foundation (GNF) and the Exploratory Technologies Department at Pfizer, Inc. Justin received a B.A. in molecular, cellular, developmental biology from the University of California, Santa Cruz and an M.B.A. from the Rady School of Business at the University of California, San Diego. Outside of work, Justin is an avid sailor with dreams of spending more time on the high seas.